Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Outset Medical Inc (NASDAQ: OM) closed at $16.9 down -3.65% from its previous closing price of $17.54. In other words, the price has decreased by -$3.65 from its previous closing price. On the day, 0.52 million shares were traded. OM stock price reached its highest trading level at $17.89 during the session, while it also had its lowest trading level at $16.77.
Ratios:
For a deeper understanding of Outset Medical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.74 and its Current Ratio is at 8.37. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.57.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 15 ’25 when Trigg Leslie sold 935 shares for $17.80 per share. The transaction valued at 16,643 led to the insider holds 58,129 shares of the business.
Nash Marc sold 252 shares of OM for $4,491 on May 15 ’25. The SVP Operations and R&D now owns 13,465 shares after completing the transaction at $17.82 per share. On May 15 ’25, another insider, Brottem John L., who serves as the General Counsel of the company, sold 396 shares for $17.82 each. As a result, the insider received 7,057 and left with 11,273 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 299506848 and an Enterprise Value of 212515040. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.60 while its Price-to-Book (P/B) ratio in mrq is 1.80. Its current Enterprise Value per Revenue stands at 1.844 whereas that against EBITDA is -2.509.
Stock Price History:
The Beta on a monthly basis for OM is 2.14, which has changed by -0.6780952 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, OM has reached a high of $55.95, while it has fallen to a 52-week low of $5.85. The 50-Day Moving Average of the stock is -11.94%, while the 200-Day Moving Average is calculated to be 20.02%.
Shares Statistics:
For the past three months, OM has traded an average of 349.84K shares per day and 297150 over the past ten days. A total of 17.72M shares are outstanding, with a floating share count of 16.94M. Insiders hold about 4.43% of the company’s shares, while institutions hold 87.80% stake in the company. Shares short for OM as of 1752537600 were 2186298 with a Short Ratio of 6.25, compared to 1749772800 on 1014324. Therefore, it implies a Short% of Shares Outstanding of 2186298 and a Short% of Float of 12.47.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The performance of Outset Medical Inc (OM) in the stock market is under the watchful eye of 4.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.88, with high estimates of -$0.61 and low estimates of -$1.61.
Analysts are recommending an EPS of between -$3.67 and -$7.98 for the fiscal current year, implying an average EPS of -$5.17. EPS for the following year is -$3.84, with 4.0 analysts recommending between -$2.25 and -$8.5.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $29.41M this quarter.It ranges from a high estimate of $29.84M to a low estimate of $29M. As of the current estimate, Outset Medical Inc’s year-ago sales were $27.39MFor the next quarter, 5 analysts are estimating revenue of $30.52M. There is a high estimate of $30.7M for the next quarter, whereas the lowest estimate is $30.3M.
A total of 5 analysts have provided revenue estimates for OM’s current fiscal year. The highest revenue estimate was $122.6M, while the lowest revenue estimate was $120.89M, resulting in an average revenue estimate of $122.02M. In the same quarter a year ago, actual revenue was $113.69MBased on 5 analysts’ estimates, the company’s revenue will be $136.51M in the next fiscal year. The high estimate is $140M and the low estimate is $134.4M.
